Fetal alcohol and drug effects

Area of Science:

• Obstetrics and Gynecology
• Neonatal Health
• Developmental Pediatrics

Background:

• Maternal substance use during pregnancy poses significant risks to embryonic and fetal development.
• Adverse outcomes include intrauterine growth retardation, birth defects, neurobehavioral alterations, and withdrawal symptoms.
• Differentiating the specific impacts of each substance on child outcomes is challenging.

Purpose of the Study:

• To review the scientific literature on the effects of maternal alcohol, cigarette, marijuana, cocaine, and opiate use on fetal and child development.
• To identify the specific risks and long-term consequences associated with prenatal exposure to various substances.

Main Methods:

• Literature review of studies examining the impact of maternal substance use on offspring.
• Analysis of reported outcomes including fetal growth, birth defects, neurobehavioral development, and long-term cognitive and behavioral function.

Main Results:

• Maternal smoking is associated with the greatest risk of impaired fetal growth and externalizing behaviors.
• Alcohol is a teratogen, with heavy exposure linked to Fetal Alcohol Syndrome (FAS) and mental retardation.
• Prenatal cocaine and marijuana exposure show limited evidence of long-term detrimental effects on cognition, though transient neurophysiological effects are noted for cocaine.
• Opiate exposure causes a withdrawal syndrome, most severe in methadone-exposed infants.

Conclusions:

• Most adverse effects of prenatal drug exposure are self-limited, with developmental catch-up and resolution of symptoms.
• Alcohol exposure is an exception, linked to permanent impairments like mental retardation and microcephaly.
• Long-term negative effects of cocaine may be underestimated due to methodological limitations in research.